XML 92 R72.htm IDEA: XBRL DOCUMENT
v3.25.2

Note 14 - Share Based Payments (Details Textual) $ / shares in Units, $ / shares in Units, $ in Thousands |  |  |  |  |  |  |  | 1 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Nov. 27, 2024 CAD ($) $ / shares | Sep. 09, 2024 CAD ($) | Aug. 28, 2024 CAD ($) $ / shares | Feb. 12, 2024 CAD ($) $ / shares | Jan. 15, 2024 CAD ($) $ / shares | Aug. 11, 2023 CAD ($) $ / shares | Nov. 15, 2022 USD ($) $ / shares | Nov. 15, 2022 USD ($) $ / shares | Dec. 20, 2024 | Dec. 31, 2024 CAD ($) $ / shares | Dec. 31, 2023 CAD ($) $ / shares | Dec. 31, 2022 CAD ($) $ / shares
Statement Line Items [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options granted in share-based payment arrangement |  |  | 250,000 | 753,923 | 25,000 |  |  |  |  | 1,028,923 | 104,080 | 115,291
Weighted average exercise price of share options granted in share-based payment arrangement (in CAD per share) | $ / shares |  |  | $ 3.28 | $ 3.24 | $ 2 |  |  |  |  | $ 3.22 | $ 8.96 | $ 18.64
Weighted average fair value at measurement date, share options granted |  |  | $ 418,000 | $ 1,377,000 | $ 29,000 |  |  |  |  |  | $ 577,000 |
Risk free interest rate, share options granted |  |  | 3.31% | 4.15% | 4.15% |  |  |  |  |  |  |
Option life, share options granted |  |  | 2 | 3 | 3 |  |  |  |  |  |  |
Expected volatility, share options granted |  |  | 93.74% | 84.64% | 86.97% |  |  |  |  |  |  |
Expected dividend, share options granted |  |  | $ 0 | $ 0 | $ 0 |  |  |  |  |  | $ 0 |
Weighted average share price, share options granted (in CAD per share) | $ / shares |  |  | $ 3.28 | $ 3.24 | $ 2 |  |  |  |  |  |  |
Number of other equity instruments exercised or vested in share-based payment arrangement |  |  |  |  |  |  |  |  |  |  | 0 |
Proceeds from exercise of warrants |  |  |  |  |  |  |  |  |  | $ 0 | $ 0 | $ 807,000
Number of other equity instruments expired in share-based payment arrangement |  |  |  |  |  |  |  |  |  |  | 245,257 |
Bottom of range [member] |  |  |  |  |  |  |  |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Risk free interest rate, share options granted |  |  |  |  |  |  |  |  |  |  | 3.37% |
Option life, share options granted |  |  |  |  |  |  |  |  |  |  | 4 |
Expected volatility, share options granted |  |  |  |  |  |  |  |  |  |  | 82.51% |
Weighted average share price, share options granted (in CAD per share) | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 3.92 |
Exercise price of outstanding share options (in CAD per share) | $ / shares |  |  |  |  |  |  |  |  |  | $ 2 | $ 9.5 |
Top of range [member] |  |  |  |  |  |  |  |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Risk free interest rate, share options granted |  |  |  |  |  |  |  |  |  |  | 4.15% |
Option life, share options granted |  |  |  |  |  |  |  |  |  |  | 5 |
Expected volatility, share options granted |  |  |  |  |  |  |  |  |  |  | 85.41% |
Weighted average share price, share options granted (in CAD per share) | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 9.6 |
Exercise price of outstanding share options (in CAD per share) | $ / shares |  |  |  |  |  |  |  |  |  | $ 24.84 | $ 29.16 |
Restricted share units [member] |  |  |  |  |  |  |  |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Number of other equity instruments granted in share-based payment arrangement |  |  |  | 26,235 |  |  |  |  |  | 26,235 | 124,968 | 12,722
Expense from share-based payment transactions |  |  |  |  |  |  |  |  |  | $ 338,000 | $ 641,000 | $ 297,000
Number of other equity instruments exercised or vested in share-based payment arrangement |  |  |  |  |  |  |  |  |  | 130,414 | 764 | 7,277
Number of other equity instruments expired in share-based payment arrangement |  |  |  |  |  |  |  |  |  | (0) | 4,750 | 1,801
Deferred share units [member] |  |  |  |  |  |  |  |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Number of other equity instruments granted in share-based payment arrangement |  | 33,891 |  |  |  |  |  |  |  | 33,891 | 104,545 | 17,868
Weighted average fair value at measurement date, other equity instruments granted |  | $ 96,000 |  |  |  |  |  |  |  |  |  |
Expense from share-based payment transactions |  |  |  |  |  |  |  |  |  | $ 218,000 | $ 586,000 | $ 189,000
Number of other equity instruments exercised or vested in share-based payment arrangement |  |  |  |  |  |  |  |  |  | 18,568 | (0) | 3,123
Number of other equity instruments expired in share-based payment arrangement |  |  |  |  |  |  |  |  |  | 12,279 | 9,332 | (0)
Options [member] |  |  |  |  |  |  |  |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Expense from share-based payment transactions |  |  |  |  |  |  |  |  |  | $ 1,212,000 | $ 513,000 | $ 505,000
Performance share units [member] |  |  |  |  |  |  |  |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Number of other equity instruments granted in share-based payment arrangement |  |  |  |  |  |  |  |  |  | 0 | 0 | 4,514
Expense from share-based payment transactions |  |  |  |  |  |  |  |  |  | $ 0 | $ 79,000 | $ 291,000
Number of other equity instruments exercised or vested in share-based payment arrangement |  |  |  |  |  |  |  |  |  | 2,083 | (0) | 7,118
Number of other equity instruments expired in share-based payment arrangement |  |  |  |  |  |  |  |  |  | 6,424 | 7,465 | 3,299
Warrants issued in November 15, 2022 Offering [member] |  |  |  |  |  |  |  |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Number of other equity instruments granted in share-based payment arrangement |  |  |  |  |  |  | 586,250 | 586,250 |  |  |  |
Weighted average fair value at measurement date, other equity instruments granted |  |  |  |  |  |  | $ 2,087 | $ 2,087 |  |  |  |
Risk free interest rate, other equity instruments granted |  |  |  |  |  |  | 4.172% | 4.172% |  |  |  |
Expected volatility, other equity instruments granted |  |  |  |  |  |  | 62.89% | 62.89% |  |  |  |
Weighted average share price, other equity instruments granted (in CAD per share) | $ / shares |  |  |  |  |  |  | $ 9.4 |  |  |  |  |
Exercise price, other equity instruments granted (in dollars per share) | $ / shares |  |  |  |  |  |  |  | $ 12.4 |  |  |  |
November 15, 2022 Offering, Broker Warrant Units [member] |  |  |  |  |  |  |  |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Number of other equity instruments granted in share-based payment arrangement |  |  |  |  |  |  | 34,538 | 34,538 |  |  |  |
Weighted average fair value at measurement date, other equity instruments granted |  |  |  |  |  |  | $ 325 | $ 325 |  |  |  |
CAD warrants [member] |  |  |  |  |  |  |  |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Number of other equity instruments granted in share-based payment arrangement |  |  |  |  |  |  |  |  |  | 1,136,364 | 5,111,364 |
Number of other equity instruments exercised or vested in share-based payment arrangement |  |  |  |  |  |  |  |  |  |  |  | 52,636
Proceeds from exercise of warrants |  |  |  |  |  |  |  |  |  |  |  | $ 807
Number of other equity instruments expired in share-based payment arrangement |  |  |  |  |  |  |  |  |  |  | 245,257 | 20,803
USD warrants [member] |  |  |  |  |  |  |  |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Number of other equity instruments granted in share-based payment arrangement |  |  |  |  |  |  |  |  |  |  | 2,699,014 | 620,788
August 11, 2023 warrants [member] |  |  |  |  |  |  |  |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Number of other equity instruments granted in share-based payment arrangement |  |  |  |  |  | 4,886,364 |  |  |  |  |  |
Weighted average fair value at measurement date, other equity instruments granted |  |  |  |  |  | $ 6,321,000 |  |  |  |  |  |
Risk free interest rate, other equity instruments granted |  |  |  |  |  | 4.68% |  |  |  |  |  |
Expected volatility, other equity instruments granted |  |  |  |  |  | 66.07% |  |  |  |  |  |
Weighted average share price, other equity instruments granted (in CAD per share) | $ / shares |  |  |  |  |  | $ 4.76 |  |  |  |  |  |
Other equity instruments life, share options granted |  |  |  |  |  | 2 |  |  |  |  |  |
Expected dividend, other equity instruments granted |  |  |  |  |  | $ 0 |  |  |  |  |  |
August 11, 2023 Broker Warrants [member] |  |  |  |  |  |  |  |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Number of other equity instruments granted in share-based payment arrangement |  |  |  |  |  | 225,000 |  |  |  |  |  |
Weighted average fair value at measurement date, other equity instruments granted |  |  |  |  |  | $ 990,000 |  |  |  |  |  |
The 2028 warrants [member] |  |  |  |  |  |  |  |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Number of other equity instruments granted in share-based payment arrangement |  |  |  |  |  |  |  |  |  |  | 2,699,014 |
Class of warrant or right, acceleration clause, stock price trigger (in CAD per share) | $ / shares | $ 3.4 |  |  |  |  |  |  |  |  | $ 4.8 |  |
The 2027 warrants [member] |  |  |  |  |  |  |  |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Number of other equity instruments granted in share-based payment arrangement | 1,136,364 |  |  |  |  |  |  |  |  |  |  |
Weighted average fair value at measurement date, other equity instruments granted | $ 1,221,000 |  |  |  |  |  |  |  |  |  |  |
Long term incentive plan [member] |  |  |  |  |  |  |  |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments granted in share-based payment arrangement |  |  |  |  |  |  |  |  | 1,825,000 |  |  |
Employee share purchase plan [member] |  |  |  |  |  |  |  |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Number of instruments granted in share-based payment arrangement |  |  |  |  |  |  |  |  |  | 250,000 |  |

X
- Definition Price of the entity's common stock which would be required to be attained for the acceleration clause of the warrant or right. + References No definition available. + Details
Name: | elbm_ClassOfWarrantOrRightAccelerationClauseStockPriceTrigger
Namespace Prefix: | elbm_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The exercise price of other equity instruments granted. + References No definition available. + Details
Name: | elbm_ExercisePriceOtherEquityInstrumentsGranted
Namespace Prefix: | elbm_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of an expected dividend used to calculate the fair value of other equity instruments granted. + References No definition available. + Details
Name: | elbm_ExpectedDividendOtherEquityInstrumentsGranted
Namespace Prefix: | elbm_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- Definition The expected volatility of the share price used to calculate the fair value of the other equity instruments granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time. + References No definition available. + Details
Name: | elbm_ExpectedVolatilityOtherEquityInstrumentsGranted
Namespace Prefix: | elbm_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The other equity instruments life of other equity instruments granted. + References No definition available. + Details
Name: | elbm_OtherEquityInstrumentsLifeShareOptionsGranted
Namespace Prefix: | elbm_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for other equity instruments granted is expressed, with a remaining term equal to the expected term of the other equity instruments being valued (based on the other equity instrument's remaining contractual life and taking into account the effects of expected early exercise). + References No definition available. + Details
Name: | elbm_RiskFreeInterestRateOtherEquityInstrumentsGranted
Namespace Prefix: | elbm_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | elbm_Statement1LineItems
Namespace Prefix: | elbm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average share price used as input to the option pricing model to calculate the fair value of other equity instruments granted. + References No definition available. + Details
Name: | elbm_WeightedAverageSharePriceOtherEquityInstrumentsGranted
Namespace Prefix: | elbm_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The option life of share options granted. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DescriptionOfOptionLifeShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The exercise price of outstanding share options. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_d&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ExercisePriceOfOutstandingShareOptions2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of an expected dividend used to calculate the fair value of share options granted. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ExpectedDividendShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 51 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_51_a&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of instruments granted in share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_a&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph IG23 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_IG23&doctype=Implementation%20Guidance -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_b&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) expired in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of share options granted in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph b -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_ii&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash inflow from the exercise of share purchase warrants. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 7 -IssueDate 2024-01-01 -Paragraph 17 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ProceedsFromExerciseOfWarrants
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph b -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_ii&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average fair value at the measurement date of granted equity instruments other than share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_b&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 47 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_a&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfEntitysOwnEquityInstrumentsAxis=ifrs-full_RestrictedShareUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfEntitysOwnEquityInstrumentsAxis=elbm_DeferredShareUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfEntitysOwnEquityInstrumentsAxis=elbm_OptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfEntitysOwnEquityInstrumentsAxis=elbm_PerformanceShareUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfEntitysOwnEquityInstrumentsAxis=elbm_WarrantsIssuedInNovember152022OfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfEntitysOwnEquityInstrumentsAxis=elbm_November152022OfferingBrokerWarrantUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfEntitysOwnEquityInstrumentsAxis=elbm_CadWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfEntitysOwnEquityInstrumentsAxis=elbm_UsdWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfEntitysOwnEquityInstrumentsAxis=elbm_August112023WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfEntitysOwnEquityInstrumentsAxis=elbm_August112023BrokerWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfEntitysOwnEquityInstrumentsAxis=elbm_The2028WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfEntitysOwnEquityInstrumentsAxis=elbm_The2027WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=elbm_LongTermIncentivePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=elbm_EmployeeSharePurchasePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |